nodes	percent_of_prediction	percent_of_DWPC	metapath
Dezocine—Equilin—SHBG—polycystic ovary syndrome	0.0483	0.499	CrCbGaD
Dezocine—Estrone—SHBG—polycystic ovary syndrome	0.0144	0.149	CrCbGaD
Dezocine—Estradiol—SHBG—polycystic ovary syndrome	0.0109	0.113	CrCbGaD
Dezocine—Estradiol—AR—polycystic ovary syndrome	0.00958	0.0988	CrCbGaD
Dezocine—Estrone—CYP1A1—polycystic ovary syndrome	0.00779	0.0803	CrCbGaD
Dezocine—Estradiol—CYP1A1—polycystic ovary syndrome	0.0059	0.0609	CrCbGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00551	0.00611	CbGpPWpGaD
Dezocine—OPRM1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00544	0.00602	CbGpPWpGaD
Dezocine—OPRK1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00539	0.00597	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00537	0.00594	CbGpPWpGaD
Dezocine—OPRM1—IL4-mediated signaling events—IRS1—polycystic ovary syndrome	0.00525	0.00581	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00521	0.00577	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00507	0.00561	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00504	0.00559	CbGpPWpGaD
Dezocine—OPRK1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00501	0.00554	CbGpPWpGaD
Dezocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00498	0.00551	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00485	0.00538	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00485	0.00537	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00485	0.00537	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0048	0.00531	CbGpPWpGaD
Dezocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00479	0.0053	CbGpPWpGaD
Dezocine—OPRK1—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00472	0.00523	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00469	0.00519	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00466	0.00516	CbGpPWpGaD
Dezocine—OPRM1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00456	0.00505	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00454	0.00502	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.0044	0.00488	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00429	0.00475	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00428	0.00474	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00426	0.00472	CbGpPWpGaD
Dezocine—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00423	0.00468	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0042	0.00465	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.0041	0.00454	CbGpPWpGaD
Dezocine—OPRM1—Opioid Signalling—POMC—polycystic ovary syndrome	0.00408	0.00452	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00405	0.00449	CbGpPWpGaD
Dezocine—OPRM1—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00399	0.00442	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00396	0.00439	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00388	0.0043	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00384	0.00425	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.0037	0.00409	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00365	0.00405	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00362	0.00401	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00357	0.00395	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00355	0.00393	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00353	0.00391	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00351	0.00389	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00344	0.00381	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00344	0.00381	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00342	0.00379	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00328	0.00364	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00327	0.00362	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00325	0.00359	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00324	0.00359	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00324	0.00359	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00319	0.00353	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00317	0.00351	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00312	0.00346	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00309	0.00342	CbGpPWpGaD
Dezocine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00306	0.00339	CbGpPWpGaD
Dezocine—OPRK1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00306	0.00339	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00303	0.00336	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00302	0.00334	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00298	0.0033	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00297	0.00329	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00294	0.00326	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00294	0.00326	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00294	0.00326	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00291	0.00322	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00291	0.00322	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00289	0.0032	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00286	0.00317	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00276	0.00306	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00275	0.00305	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00274	0.00303	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00274	0.00303	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.0027	0.00299	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00268	0.00296	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00267	0.00296	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00262	0.0029	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00261	0.00289	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.0026	0.00288	CbGpPWpGaD
Dezocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00259	0.00286	CbGpPWpGaD
Dezocine—OPRM1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00258	0.00286	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00256	0.00284	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00249	0.00276	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00249	0.00276	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00249	0.00276	CbGpPWpGaD
Dezocine—OPRK1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00244	0.0027	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00242	0.00268	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00241	0.00267	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00238	0.00264	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00237	0.00263	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00237	0.00262	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00233	0.00258	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00226	0.0025	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00222	0.00245	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.0022	0.00244	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.0022	0.00243	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00217	0.0024	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00216	0.00239	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00209	0.00231	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00208	0.00231	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00206	0.00229	CbGpPWpGaD
Dezocine—OPRM1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00206	0.00228	CbGpPWpGaD
Dezocine—OPRK1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00206	0.00228	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00204	0.00226	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00202	0.00223	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00201	0.00223	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00201	0.00222	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.002	0.00221	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.002	0.00221	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00197	0.00218	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00193	0.00214	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.0019	0.0021	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00188	0.00209	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00187	0.00208	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00185	0.00205	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00185	0.00204	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00183	0.00203	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00183	0.00203	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00182	0.00202	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00177	0.00196	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00176	0.00195	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00176	0.00195	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00174	0.00193	CbGpPWpGaD
Dezocine—OPRM1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00174	0.00193	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00174	0.00193	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00174	0.00193	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00171	0.00189	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00169	0.00187	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00168	0.00186	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00167	0.00184	CbGpPWpGaD
Dezocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00164	0.00181	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00163	0.00181	CbGpPWpGaD
Dezocine—OPRM1—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.00163	0.0018	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00163	0.0018	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.0016	0.00178	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00159	0.00176	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00158	0.00175	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00158	0.00175	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00156	0.00173	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00156	0.00173	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00155	0.00171	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00154	0.0017	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.0015	0.00166	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00148	0.00164	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00147	0.00163	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00147	0.00163	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00142	0.00157	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.0014	0.00155	CbGpPWpGaD
Dezocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00138	0.00153	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00137	0.00152	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00136	0.00151	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00133	0.00148	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.0013	0.00144	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00127	0.00141	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00127	0.0014	CbGpPWpGaD
Dezocine—OPRK1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00125	0.00138	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00124	0.00137	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.0012	0.00133	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00118	0.00131	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00116	0.00129	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00115	0.00128	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.00113	0.00126	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00113	0.00125	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00112	0.00124	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00111	0.00123	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00108	0.0012	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00108	0.00119	CbGpPWpGaD
Dezocine—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00105	0.00117	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00105	0.00116	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00105	0.00116	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00105	0.00116	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00104	0.00115	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00102	0.00113	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00101	0.00112	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00099	0.0011	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000984	0.00109	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000973	0.00108	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000965	0.00107	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000959	0.00106	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000954	0.00106	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00095	0.00105	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000947	0.00105	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000936	0.00104	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000915	0.00101	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000901	0.000997	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000888	0.000984	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000886	0.000981	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000884	0.000979	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000877	0.000971	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000866	0.000959	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000849	0.000941	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000837	0.000927	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000822	0.000911	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000815	0.000903	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000807	0.000894	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000803	0.000889	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000794	0.00088	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000786	0.000871	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000761	0.000843	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000751	0.000831	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000731	0.00081	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000731	0.00081	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000718	0.000795	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000704	0.00078	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000698	0.000772	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000682	0.000755	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00068	0.000753	CbGpPWpGaD
Dezocine—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000677	0.00075	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000671	0.000744	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000665	0.000736	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000644	0.000713	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00064	0.000708	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000638	0.000706	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000618	0.000684	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000618	0.000684	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000615	0.000681	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000605	0.00067	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000595	0.000659	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00059	0.000653	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000575	0.000637	CbGpPWpGaD
Dezocine—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000572	0.000634	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000561	0.000621	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000544	0.000602	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000541	0.000599	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000539	0.000597	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000535	0.000592	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000525	0.000581	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00052	0.000575	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000512	0.000566	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000474	0.000525	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000452	0.0005	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000449	0.000498	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000443	0.000491	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.00044	0.000487	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000392	0.000435	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00038	0.000421	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000378	0.000418	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.000376	0.000416	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000372	0.000412	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000363	0.000402	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000363	0.000402	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000345	0.000382	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000332	0.000367	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000319	0.000354	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000318	0.000352	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000307	0.00034	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000307	0.00034	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000292	0.000323	CbGpPWpGaD
Dezocine—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000278	0.000308	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000237	0.000263	CbGpPWpGaD
Dezocine—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000235	0.00026	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000201	0.000222	CbGpPWpGaD
Dezocine—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000164	0.000182	CbGpPWpGaD
Dezocine—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000139	0.000154	CbGpPWpGaD
